Rage1979

A View from Pfizer's Corner Offices

It would seem to me that advances in fully differentiated hESC's and iPS cells will provide another tool in the scrutiny of drug candidates. Effective employment of the correct model cells, although not a 100% perfect analysis tool, shall certainly help pull out more and more outliars in the process. Thus, directly saving money avoiding unnessecary trials and more importantly increasing the potential safety to future patients.

More on 'Big Pharma Maintains Illusion of Innovation' (Response to Ken Johnson)

I am a pharmacuetical lawyer, so I do know the regulations quite well. What the law says and what happens in practice are two different things. The law says alot of things, like you must state clearly and unambigously the known side effects of drugs; do pharma companies abide by that one too?

Being an in house, I understand what is going on and see it everyday....the laws are FILLED with loopholes, so don't be so naive

More on 'Big Pharma Maintains Illusion of Innovation' (Response to Ken Johnson)

The razor thin line between "marketing" and "educating" doctors about different treatment options (products) is the problem. Yes, the patient benefits when the physcian is up to date on new treatment options; however, not when the doctor gets a full week "conference" in Monte Carlo, with just one 3 hour seminar where all you can drink booze is served.

Promoting/Marketing/Pu... drugs, aka, being awarded recognition trips to speak at seminars in 5 star resorts, is not the solution. Drugs and healthcare should NEVER be compared with retail or technology products (these are discretionary sectors). In one way the FDA regulates drugs for safety and effectiveness; then it turns its head when it is being over-prescribed so Dr. Doe can get him and his wife a cruise.

You heavily regulate a product on one hand and then allow general consumer promotion on the other...just another sad example of talking out of both sides of your mouth.

Oh yeah, get over this anti-captialism tirade...liptor make 8 BILLION USD A YEAR....even when it is not necessarily the best treatment option...now thats capitalism if I have ever seen it.

Four Promising Embyronic Stem Cell Stocks

Can you post anything relevant besides your standad KOOL pump message? Look at this guys message history..Since you clearly want to talk about KOOL, I suggest you write you own article. There are alot of interesting stem cell plays, and not every article has to name every company..

Expecting Post-Stimulus Catalyst for Stem Cell Research Companies

Intellectual Property controls and drives this sector (and will for the foreseeable future). By that analysis there are only two real players in the broader stem cell market (GERN/ACTC). Some others are niche plays within the market, but almost all other companies will need to license one or more patents from GERN or ACTC.

Dont be fooled by companies that trend water off their fancy "stem cell" related names...

Geron Corp: Up 50% on Nothing but Hope

Very little money has been comparatively spent in the foundational science. Companies, who are burned as the collective cross, for funding embryonic stem cell research have the court of the misinformed public to face and answer to. Bush's ideological equivalent of banishing Galieo for correctly and scientifically recognizing that the sun was at the center of the universe, has created a backlash against science, facts, biotechnology and any other sector that touches of the so called morality of life...ironic that war and defense did not include such compassion.

To compare adult stem cells or iPS cells to HESC is naive, and grossly misinformed. You clearly did not research your article on State appropriations either, as this money has only very recently begun tickling out and primarily to foundational science, not clinical applications. Further, to discount the effect that the NIH and Federal money has on a sector, you should only consider the nightmarish environment that basic research scientist had to live in under a restrictive regime that requires HESC prior 2001 and post 2001. Fear of losing grant money, various other forms of federal support and once again the court of misinformed public all weigh heavily on an instititutions decision to engage in this type of work.

If you take the time to actually craft an argument, remember to support it with truth; science requires a logical proof...not an opinionated "unreasoned" assumption.